Statistical issues and challenges in post-licensure safety surveillance and treatment effect assessment: Panel Discussion
Thomas E MaCurdy, Stanford University/Acumen LLC  *David Martin, FDA/CBER  Ravi Varadhan, Johns Hopkins University  Priscilla Velentgas, Quintiles Outcome 


Drs. Tom MaCurdy, Ravi Varadhan, and Priscilla Velentgas will be joined by Dr. David Martin from the FDA for a panel discussion. Dr. Martin will commence the panel discussion by offering comments. Speakers will be given a chance to respond and then questions from the audience will be encouraged.